| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An overview of adjuvant chemotherapy for resected non-small cell lung cancer: focus on the ECOG 1505 phase III trial
|
Socinski, Mark A.
|
|
2008
|
5 |
8 |
p. 457-463
7 p.
|
artikel
|
| 2 |
In-depth updates and reviews, and a plea for streamlining research paperwork
|
Bosserman, Linda D.
|
|
2008
|
5 |
8 |
p. 425-
1 p.
|
artikel
|
| 3 |
KRAS mutational analysis: pathology's perspective
|
Dixon, Lisa R.
|
|
2008
|
5 |
8 |
p. 436-
1 p.
|
artikel
|
| 4 |
KRAS mutational analysis: ready for prime time?
|
George Jr., Thomas J.
|
|
2008
|
5 |
8 |
p. 435-436
2 p.
|
artikel
|
| 5 |
KRAS status as a predictor of response to EGFR inhibitors in mCRC
|
Abraham, Jame
|
|
2008
|
5 |
8 |
p. 433-435
3 p.
|
artikel
|
| 6 |
Mantle cell lymphoma: an overview of diagnostic and therapeutic advances
|
Harris, Thomas J.
|
|
2008
|
5 |
8 |
p. 465-472
8 p.
|
artikel
|
| 7 |
Metastatic melanoma: an AJCC review
|
Agarwala, Sanjiv S.
|
|
2008
|
5 |
8 |
p. 441-445
5 p.
|
artikel
|
| 8 |
Synchronous hilar cholangiocarcinoma and gallbladder cancer
|
Naik, Seema
|
|
2008
|
5 |
8 |
p. 447-451
5 p.
|
artikel
|
| 9 |
The FDA draws upon new authority to mandate elements of ESA labeling
|
Marson, Brian
|
|
2008
|
5 |
8 |
p. 455-456
2 p.
|
artikel
|
Tijdschrift beschrijving